The Role of Clostridium perfringens Toxins in Gas Gangrene

From MicrobeWiki, the student-edited microbiology resource
Jump to: navigation, search
This is a curated page. Report corrections to Microbewiki.

What is Gas Gangrene and What Causes It?


By Marysol Arce


A patient's right thigh severely affected by gas gangrene. Courtesy of Cases Journal, 2008, Vol. 1, Issue 252, published on BioMed Central (http://casesjournal.biomedcentral.com/articles/10.1186/1757-1626-1-252.

Gas gangrene, or myonecrosis, is a form of gangrene and bacterial infection that produces toxins which lead to gas build up inside the tissues. The gas is produced through glucose fermentation, and is usually composed of 5.9% hydrogen, 3.4% carbon dioxide, 74.5% nitrogen, 16.1% oxygen [1]. Gas gangrene is caused by a rod shaped, gram positive, spore forming bacterium called Clostridium perfringens. The bacterium lives in anaerobic environments like the soil and inside the gut of humans and animals [2]. Clostridium perfringens is currently known to have five different strains, marked as: A, B, C, D, and E [3]. The different strains are classified based on which toxins they produce: alpha toxin, beta toxin, epsilon toxin, and/or iota toxins [4]. The Clostridium perfringens A strain is of the most importance because it causes gas gangrene, or myonecrosis, in humans. Gangrene is the death of body tissue and usually seen in elderly people or diabetic people. Open wounds or trauma into deep tissue that become infected by bacteria also become gangrenous. Gas gangrene is an especially dangerous form because it spreads quickly throughout the body if left untreated, and can be fatal. C. perfringens produces toxins that kills cells and releases gas, leaving parts of the body black, purple, and covered with blisters.


The A strain of the C. perfringens bacterium produces two important toxins that enable the spread of the bacterium and tissue death: the alpha toxin and perfringolysin O [5]. The alpha toxin, also known as CPA or PLC, is a crucial virulence factor for this bacterium because gas gangrene cannot occur without it. However, the alpha toxin and perfringolysin O (PFO) work synergistically to accomplish the spread of infection [6]. The toxins can cause septic shock (when infection leads to very low blood pressure) and hypoxia (reduced amounts of oxygen to body tissues). It even causes organ failure and muscle degeneration due to the lack of oxygen and reduced blood flow. The degeneration of the muscle and tissue releases gas that builds up under the skin and makes the area blister and bubble. The appearance of these blisters in various parts of the body usually indicates that the infection has progressed very far and that the tissue is decomposing. The body’s immune system is also rendered helpless because the toxins make the leukocytes clump together and clog in the blood vessels (leukostasis), unabling them to get to the site of infection [7]. The toxins also cause further blood vessel dysfunction, like vascular leakage which is what makes swelling a big characteristic of this disease.

Clostridium perfringens genome

The bacterium Clostridium perfringens’ genome is a lone circular chromosome with additional plasmids that are extra-chromosomal, meaning that there is other DNA found outside of the nucleus [8]. It is made up of 2,660 regions that encode proteins and 10 ribosomal RNA genes [4]. The genome also possesses the anaerobic fermentation enzymes usually found in bacterium that allow for gas production. However, it does not have any tricarboxylic acid (TCA) cycle enzymes or for a respiration mechanism. Many saccharolytic enzymes are present but most of the enzymes needed in amino acid biosynthesis are not present in the genome. There are at least 20 genes that encode virulence factors for the bacterium and 5 hyaluronidase genes, which encode enzymes that degrade hyaluronic acid, that also add to C. perfringens virulence [4]. Hyaluronic acid is a viscous fluid carbohydrate that is present in connective tissues, epithelial tissues, and the eyes. It is a major component of the skin and tissue, and involved in the repair of skin cells. When we age, we get wrinkles and our skin sags, becoming dehydrated. It is because we lose hyaluronic acid in our skin the older we get. Therefore, the loss of hyaluronic acid plays a major role in skin degradation. The degradation of tissue by lack of hyaluronic acid in the skin supplements the bacterium in further destruction of the host’s cells and tissue. There are also 4 regulons that regulate the pathogenicity, the ability of the organism to cause disease, of the bacterium. Clostridium perfringens utilizes and gains many different crucial materials needed to perform their function from the host cells by producing many degradative toxins and enzymes. To obtain what they need, the bacterium uses these toxins and enzymes to destroy the host’s tissues and cells. The two critical toxins of C. perfringens A strain, alpha toxin and perfringolysin O, are both chromosomally encoded [9].

Alpha Toxin (PLC)

Alpha toxin attachment and insertion into host cell membrane. Courtesy of The Jounal of Biochemistry, 2004, Vol. 136, Issue 5, 569-574, published on Oxford Journals (http://jb.oxfordjournals.org/content/136/5/569.long.


All strains of C. perfringens can produce the alpha toxin, also known as Clostridium perfringens alpha toxin (CPA) or by its main enzyme, phospholipase C (PLC) [9]. The alpha toxin is the most toxic enzyme that is produced by the A strain, and is also a crucial virulence factor. It has phospholipase C and sphingomyelinase that hydrolyzes phosphatidylcholine (PC) and sphingomyelin (SM), two very important components of a eukaryotic cell membrane [6]. PLC or phospholipase C is an enzyme that cleaves phospholipids inside cell membranes, just before the phosphate group. SMase is a hydrolase enzyme that is part of the DNase family. It breaks down sphingomyelin into phosphocholine and ceramide. The breakdown of sphingomyelin is detrimental to the body because it is abundant in the myelin sheath that surrounds nerve cell axons of the body. Without sphingomyelin, the neurons’ axons will not be covered and therefore will not be electrically insulated. The myelin sheath is important in the transport of the action potential down the axon and delivering messages from the brain to other parts of the body. Therefore, alpha toxin can hinder the immune system’s response by damaging the nerve cells. If messages about the whereabouts of the attacking pathogen cannot be transmitted, the immune system will not know how to respond and attack. Alpha toxin also degrades PC and SM in membranes and disrupts membranes, leading to cell lysis. For the alpha toxin to break down the host cell’s membrane, it promotes carboxyfluorescein (CF) leakage and phosphorylcholine release from the host’s liposomes which are made up of either PC or SM [3]. By cleaving molecules from the exterior of the host cell's phospholipid bilayers and interrupting the membrane’s functions, it then promotes cell lysis and ultimately death. The alpha toxin’s membrane-damaging ability is also dependent of the membrane’s fluidity. Other actions caused by the toxin are hemolysis (rupture of red blood cells), dermonecrosis (death of skin tissue due to lack of blood flow), and lethality [3].

Different pathways that signal for alpha toxin induced hemolysis, contraction of blood vessels, and other effects. Courtesy of The Jounal of Biochemistry, 2004, Vol. 136, Issue 5, 569-574, published on Oxford Journals (http://jb.oxfordjournals.org/content/136/5/569.long.


The alpha toxin promotes endothelial cells, cells that line the inside of blood vessels, to produce intercellular mediators. These intracellular mediators bring about the effects of the toxin. The alpha toxin produces these intracellular mediators: intercellular adhesion molecule 1, an endothelial leukocyte adhesion model, and a platelet activating factor [3]. The toxin induces the relocation of the platelet fibrinogen receptor from the inside of the platelet to its membrane. This relocation then triggers the formation of more platelets and platelet aggregates [3]. These actions contribute greatly to an elevated vascular permeability and leads to edema, defined by the buildup of fluid in the tissues. Essentially, the alpha toxin is able to escape the leukocytes and move out of the blood vessels and into the cells. The leukocytes are unable to move or stop the infection because they are stuck with the platelets and can only watch while the toxin kills the tissues. Researchers have also discovered that the activation of the sphingomyelin (SM) cycle is a fundamental event within the signal transduction pathway that takes part in cellular proliferation, differentiation, and apoptosis [3]. A crystallography of alpha toxin reveals its structure to be composed of two domains: the N domain and the C domain. The N domain is composed of 9 ⍺-helices that are tightly packed together. The C domain consists of an 8 stranded antiparallel β-sandwich motif [3]. The N domain also includes 3 divalent cations that contain zinc ions in the active site [3]. Zinc is critical for the alpha toxin because without it, the toxin cannot be activated. Therefore, zinc is essential for the alpha toxin’s activity in vivo and has also been found to enhance alpha toxin production in vitro [7]. The C domain of alpha toxin also performs the most important part when lysing the host cells. The C domain is the part of the alpha toxin that is inserted into the host cell’s phospholipid bilayer to disrupt the membrane [3]. The two domains are also highly crucial in hemolysis, the destroying of erythrocytes, or red blood cells. The N domain itself cannot bind or lyse the them; the C domain must be the one to bind to the red blood cell’s membrane [10]. Then by combining the N domain and C domain, the alpha toxin gets it hemolytic power. To summarize, the alpha toxin elicits biological activities and processes that are inherent to tissues and cells. First, the toxin attaches to the binding site on the exterior of the membrane, then the C domain inserts itself into the host membrane. Next, the N domain follows: attacking and hydrolyzing the PC and SM within the membrane. The hydrolysis stimulates the signal transduction pathway through activation of phospholipase C and / or SMase [3].

Perfringolysin O (PFO)

All strains of C. perfringens can produce the toxin perfringolysin O (PFO). The structure of PFO is a signal peptide that is secreted by the general secretory pathway (GSP) in the bacterium. When this signal peptide passes through the cell membrane, it is cleaved, resulting in an water-soluble monomer in the extracellular space. This toxin is part of a pore-forming toxin family, the cholesterol-dependent cytolysin (CDC) family [8]. The PFO that was secreted as the water-soluble monomer can only recognize and bind to cholesterol in the plasma membrane [8]. Cholesterol is common component of animal cells and is required for the toxin to perform its function. Once recognizing and attaching to cholesterol in the membrane, PFO oligomerizes at the host cell’s exterior and constructs a pore complex. Next it inserts itself into the cell membrane to form a large pore [9]. The formation of this large pore disrupts the cell membrane, which causes cell lysis and cell death. But has been thought that cell lysis is not the main biological effect of this toxin on C. perfringens affected tissue [9].

Perfringolysin O binding with the phospholipid bilayer. Courtesy of Toxins Journal, 2015, Vol. 7, Issue 5, 1702-1721, published on MDPI: Open Access (http://www.mdpi.com/2072-6651/7/5/1702/htm.

PFO, as well as the alpha toxin, prevents white blood cells from arriving at the site of infection. Alpha toxin promotes the production of adhesion molecules and platelet activation factors, which clog the up the host’s blood vessels and disallow the passage of white blood cells to the infection site. Because the body’s immune system is not able to fight the bacterium at the site of infection, the toxin aids in the decay of flesh and tissue. Although the alpha toxin is critical to the virulence, PFO is not. Even though it may not be essential, it is synergistic with the alpha toxin [6]. If a person was infected with a mutant strain of C. perfringens that doesn’t produce PFO, they would still be affected with gas gangrene, just at a slower rate than when infected with a wild type strain. PFO may not be required for infection but it certainly helps with the rate of infection. When two things work in synergy with each other, it means that they benefit and amplify each other’s effects. Therefore, having both toxins would allow the bacteria to spread faster and easier than having only the alpha toxin. Both act together and boost the effect of the disease to speed up necrosis. If the host’s cells are lysed it makes it easier for the bacterium to infiltrate the cell and speeds up the process of necrosis. PFO is also like a double edged sword: it has a separate function in different stages of gas gangrene infection. In the early stages of infection, it causes macrophage cytotoxicity [5]. In the later stages of infection, it causes thrombosis, which is the clotting of blood cells in the blood vessels [6]. Although PFO plays a big role in thrombosis, the alpha toxin does as well, and the two work synergistically (described further in the section: Synergy of Alpha Toxin and Perfringolysin O to Spread Gas Gangrene). To summarize PFO’s mechanism in cell lysis and furthering the infection, there are four main steps. First, the toxin binds to the cholesterol inside membranes. Second, it inserts itself into the membrane. Third, it oligomerizes, and fourth, it forms a pore that disrupts the cell [11].


An Experimental Example That Determines the Importance of Alpha Toxin and PFO

David O’Brien and Stephen Melville tested the effects the C. perfringens alpha toxin and PFO might have on cytotoxicity to macrophages, and if they help the bacterium escape phagosomes of the host’s immune system. They made a strain of C. perfringens (DOB3) that does not produce PFO but produces alpha toxin and another strain (DOB4) that does not produce either PFO or alpha toxin. They also used the PLC- strain which only produces PFO and not the alpha toxin, found from a separate study. They also had the wild type strain of C. perfringens to serve as the control. They then incubated these different strains of C. perfringens cells in tissue culture plates with macrophages taken from the cells of the abdominal cavity in mice [5]. They tested two different conditions as well, observing the bacterium and macrophages under aerobic and anaerobic conditions. A lower number of bacteria was added to the plates under anaerobic conditions because high numbers were found to be deadly to macrophages under anaerobic conditions [5]. They then ran an assay to determine the cytotoxicity of the different strains of the bacterium, and the amount of cytotoxicity is determined by the percentage of macrophages lysed.

Cytotoxicity measured by percentage of macrophages lysed by different strains of C. perfringens. Courtesy of Infection and Immunity, 2004, Vol. 72, Issue 9, 5204-5215, published on American Society for Microbiology (http://iai.asm.org/content/72/9/5204.long.

In order to test the importance of the roles of the alpha toxin and PFO, they administered two different doses: a lethal dose (10⁹) and a sub-lethal (10⁶) dose of the bacterium to mice. They found that at the high dose only PLC was needed for the bacterium to persist in the host’s tissues but at the low dose both PLC and PFO was needed for the bacterium to survive in the tissues [5]. Both are needed when it is only a low dose because when the number of bacterium is lower than the number of macrophages and phagocytes, the bacterium needs more assistance in surviving and escaping the host’s immune system [5].

How Do These Toxins Help C. perfringens Persist and Spread in the Body?

Alpha Toxin and PFO Allow C. perfringens to Escape from Macrophages and the Immune System

C. perfringens is able to avoid and escape its host’s the immune system’s phagocytic cells, especially polymorphonuclear cells (PMNs). Because gas gangrene develops until it can finally be seen, which usually means the infection is severe, it shows that the macrophages and other white blood cells cannot kill the bacterium efficiently [5]. Macrophages are usually the primary immune response to kill bacteria and if they are not killing bacteria effectively, the infection will only get worse and spread. Macrophages perform phagocytosis on the bacteria to break them down into particles called antigens. They then present the antigens to a B cell, which will makes a specific antibody for a specific antigen. The antibody will bind to the antigen and mark it so it will be destroyed. Therefore, if the macrophages are ineffective in catching the bacteria and cannot even supplement the immune response to call in B cells and T cells, the infection will intensify and the host will die. Essentially, the immune response is powerless. The ineffectiveness of the phagocytic cells like PMNs is attributed to the alpha toxin and perfringolysin O (PFO). Purified PFO has been seen to have cytotoxicity to PMNs in vitro while purified alpha toxin (PLC) has been seen to have little cytotoxicity to PMNs in vitro [5]. Therefore, although both toxins play a role in the weakening of the body’s immune response, PFO might have a greater cytotoxic effect on macrophages than the alpha toxin.


C. perfringens also shares similarities with pathogens like species of Listeria and Shigella, which escape the phagosome of macrophages and replicate in the cytoplasm. Although the ability of the bacterium to escape phagosomes is known, it is unclear if it is able to replicate in the cytoplasm [5]. Both the alpha toxin and PFO are membrane-active toxins which make them helpful in escaping the phagosome. Because PFO oligomerizes to construct large pores on cholesterol-possessing membranes, it could have the ability to lyse the phagosome’s membrane and allow for escape. But the alpha toxin has a lower ability of mediating phagosomal escape. Therefore, the alpha toxin alone cannot mediate escape and survival inside the macrophages [5]. Both the alpha toxin and the PFO must work together to yield the best, most efficient means of phagosomal escape.


Host Defense Against C. Perfringens and Host Surrender to C. Perfringens

The host has a weak defense against C. perfringens and is more easily overtaken as time passes. In the earliest stages of infection, the primary host defense is most likely the phagocytes of the innate immune system, which are primarily macrophages and polymorphonuclear cells (PMNs). As the infection progresses to its later stages where the bacteria have proliferated enough so that the gas gangrene is visible, there is a significant scarcity of phagocytes near the where the bacterium are. A lack of oxygen in the wound area also aids in the growth of anaerobic C. perfringens, which is helpful to gas gangrene because it usually begins in dead tissue. All living tissues need oxygen carried by blood to survive. When tissue does not receive or stops receiving oxygen, it dies. This death of tissue is what leads to gangrene. This environment is ideal for anaerobic C. perfringens because of the lack of oxygen and because the immune system can no longer attack it due to lack of blood flow to the affected area.

Synergy of Alpha Toxin and Perfringolysin O to Spread Gas Gangrene

The alpha toxin is a requirement for: tissue necrosis, the obstruction of polymorphonuclear leukocytes (PMNL) increase into the infection site, and development of thrombosis [6]. Thrombosis, or blood clotting, is especially important for gas gangrene to resist the immune system’s attack because it reduces the oxygen tension in tissues. This provides a suitable environment for anaerobic C. perfringens to grow. It is has been discovered that purified alpha toxin induces aggregation of platelets in the blood vessels. Because the platelets are clumped together and blocking the way in the blood vessels, the leukocytes cannot pass through and travel to the infected tissues to fight the infection. Therefore, the alpha toxin plays a major part by reducing blood flow and fighting the host’s immune system to enable further infection.


PFO, like the alpha toxin, plays a similar role in the build up of leukocytes inside blood vessels and the extracellular space of host tissues [7]. PFO causes a heightened expression of adhesion molecules like those of leukocytes, and the platelet activating factor of human endothelial cells [8]. This increase in expression the platelet activating factor and the endothelial cell adhesion factor contribute to platelet-leukocyte masses sticking onto the lining of the blood vessels and blocking them [12]. Platelets are tiny blood cells that forms clots to help stop bleeding. If more platelets in addition to the normal amount are released into the bloodstream, they will clump together and form a clot, blocking the passage of red blood cells and leukocytes. The endothelial cell adhesion factor allows leukocytes to bind to the blood vessel walls. Because leukocytes are bigger than red blood cells, if they build up they will also block the red blood cells from passing. Again, if the blood vessels become blocked, it leads to thrombosis and reduced blood flow. Without oxygen going to the tissues, anaerobic C. perfringens can flourish and further necrosis. Perfringolysin O also furthers the spread of infection by lysing red blood cells. Red blood cells are important machinery of humans that carry oxygen through the blood vessels to our tissues. If our red blood cells are destroyed or lysed by PFO, there will be no way for oxygen to travel to parts of our body and our cells will die. In this way, PFO has two mechanisms to prevent the immune system from fighting the infection: by blocking blood vessels so that white blood cells cannot travel to the infection and by lysing the very cells that carry the necessary oxygen we need to function.


Awad and colleagues held an experiment where they infected mice with the wild type strain of C. perfringens bacteria that produced the typical symptoms of gas gangrene with thrombosis and vascular leukostasis. Then they infected another group of mice with a strain that was void of the genes that enabled production of alpha toxin and PFO. This group of mice showed very little symptoms of gas gangrene and little to no leukostasis in the blood vessels was seen. The leukocytes were able to travel to the infected tissues and fight the infection. They concluded from this experiment that both toxins are needed to work synergistically to allow the bacterium to evade the immune system and survive inside the host [6].


Role of the Alpha Toxin and Perfringolysin O in: Cytotoxicity Towards Macrophages and the Ability to Escape From Phagosomes of Macrophages

PFO was discovered to have an essential part in both cytotoxicity and escape of macrophages, therefore making it a crucial virulence factor of gas gangrene, helping the bacterium resist being killed by macrophages. In O’Brien and Melville’s experiment, they examined the role of PFO in the early stages of gas gangrene infection, at a time when the number of bacteria present was few relative to the number of phagocytic cells. They found that for the C. perfringens bacterium to persist in the host’s tissues, PFO was equally mandatory as the alpha toxin. This supports the crucial role PFO plays in the early stages of gas gangrene infection, where the ratio of bacterial cells to phagocytic cells is relatively low [5]. Once the bacterium resists being killed by the macrophages and PMNs early into the infection, it is able to continue its spread deeper in the tissues. We can conclude that PFO is more crucial than the alpha toxin, although having both would be a bigger advantage in the spread of the infection than having just one toxin. PFO is the more important factor of cytotoxicity of the two [8].

Treatments Against Gas Gangrene

Gas gangrene is much easier to treat if caught early, but symptoms may not be visible until severe stages. One mode of treatment is antibiotic therapy. The most common antibiotics used are penicillin and clindamycin, and both are usually used simultaneously [13]. There have also been recent studies conducted that protein synthesis inhibitors might be more effective ways of treatment than antibiotics. If doctors are able to block the synthesis of C. perfringens alpha toxin and perfringolysin O, they can reduce the amount of toxins inside the patient’s body and therefore lessen the effects of these toxins. People affected by gas gangrene are also usually affected by organ failure. They need intensive care due to necrosis affecting organs. Another mode of treatment is hyperbaric oxygen therapy, or HBO therapy [13]. Although it has been used in the U.S. for gas gangrene treatment for a long time, it is controversial. The treatment involves administering 100% oxygen to patients for prolonged periods of time. Studies for this type of treatment on gas gangrene have reported that it inhibits alpha toxin production and makes the living and dead tissue more visible from each other. Therefore, this treatment is most likely better to use before surgery, excision, or amputation. There are however some risks like trauma resulting from pressure and oxygen toxicity. Ultimately, if gas gangrene of a patient cannot be treated with any of these methods, they will have to undergo surgery and/or amputation [13]. The necrotic tissue must be cut off and physically removed so that it does not spread further in the body. If whole limbs are necrotic, they must be amputated. Removal of parts of the body is much better than letting the infection spread more and leading to death.

Gas Gangrene in Animals

Gas gangrene is not just limited to humans. Many agricultural animals like cattle, sheep, and horses can also suffer from it. Their symptoms are similar to humans: edema, emphysema, skin discoloration, and toxemia [9]. It is assumed that the main virulence factors for gas gangrene in animals is the alpha toxin (CPA) and perfringolysin O (PFO) like humans because of the similarity in symptoms [9].


References

  1. [[1] Chi, CH, KW Chen, JJ Huang, YC Chuang, and MH Wu. "Gas Composition in Clostridium Septicum Gas Gangrene." 1995. J Formos Medical Association. 94(12):757-59.]
  2. [[2] Williamson, E. D., and R. W. Titball. "A Genetically Engineered Vaccine against the Alpha-toxin of Clostridium Perfringens Protects Mice against Experimental Gas Gangrene." 1993. Vaccine. 11(12):1253-258. DOI:10.1016/0264-410X(93)90051-X]
  3. 3.0 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 3.9 [[3] Sakurai, Jun, Masahiro Nagahama, and Masataka Oda. "Clostridium Perfringens Alpha Toxin: Characterization and Mode of Action." 2004. The Journal of Biochemistry 136(5):569-74. DOI: 10.1093/jb/mvh161]
  4. 4.0 4.1 4.2 [[4] Shimizu, Tohru, Kaori Ohtani, Hideki Hirakawa, Kenshiro Ohshima, Atsushi Yamashita, Tadayoshi Shiba, Naotake Ogasawara, Masahira Hattori, Satoru Kuhara, and Hideo Hayashi. "Complete Genome Sequence of Clostridium Perfringens, an Anaerobic Flesh-eater." 2002. Proceedings of the National Academy of Sciences of the United States of America 99(2):996-1001. DOI: 10.1073/pnas.022493799]
  5. 5.00 5.01 5.02 5.03 5.04 5.05 5.06 5.07 5.08 5.09 5.10 [[5] O'Brien, David K., and Stephen B. Melville. "Effects of Clostridium Perfringens Alpha-Toxin (PLC) and Perfringolysin O (PFO) on Cytotoxicity to Macrophages, on Escape from the Phagosomes of Macrophages, and on Persistence of C. Perfringens in Host Tissues." 2004. Infection and Immunity 72(9):5204-215. DOI: 10.1128/IAI.72.9.5204-5215.2004]
  6. 6.0 6.1 6.2 6.3 6.4 6.5 [[6] Awad, Milena M., Darren M. Ellemor, Richard L. Boyd, John J. Emmins, and Julian I. Rood. "Synergistic Effects of Alpha-Toxin and Perfringolysin O in Clostridium Perfringens-Mediated Gas Gangrene." 2001. Infection and Immunity 69(12):7904-910. DOI: 10.1128/IAI.69.12.7904–7910.2001]
  7. 7.0 7.1 7.2 [[7] Stevens, Dennis L., and Amy E. Bryant. "The Role of Clostridial Toxins in the Pathogenesis of Gas Gangrene." 2002. Clinical Infectious Diseases. 35:S93-100. DOI: 10.1086/341928]
  8. 8.0 8.1 8.2 8.3 8.4 [[8] Verherstraeten, Stefanie, Evy Goossens, Bonnie Valgaeren, Bart Pardon, Leen Timbermont, Freddy Haesebrouck, Richard Ducatelle, Piet Deprez, Kristin R. Wade, Rodney Tweten, and Filip Van Immerseel. "Perfringolysin O: The Underrated Clostridium Perfringens Toxin?" 2015. Toxins 7(5):1702-721. DOI: 10.3390/toxins7051702]
  9. 9.0 9.1 9.2 9.3 9.4 9.5 [[9] Li, Jihong, Vicki Adams, Trudi L. Bannam, Kazuaki Miyamoto, Jorge P. Garcia, Francisco A. Uzal, and Julian I. Rood. "Toxin Plasmids of Clostridium Perfringens." 2013. Microbiology and Molecular Biology Reviews 77(2):208-33. DOI:10.1128/MMBR.00062-12]
  10. [[10] Nagahama, Masahiro, Masakazu Mukai, Shinsuke Morimitsu, Sadayuki Ochi, and Jun Sakurai. "Role of the C-Domain in the Biological Activities Of Clostridium Perfringens Alpha-Toxin." 2002. Microbiology and Immunology. 46(10):647-55. DOI:10.1111/j.1348-0421.2002.tb02748.x]
  11. [[11] Shimada, Yukiko, Megumi Nakamura, Yasuhide Naito, Kohji Nomura, and Yoshiko Ohno-Iwashita. "C-terminal Amino Acid Residues Are Required for the Folding and Cholesterol Binding Property of Perfringolysin O, a Pore-forming Cytolysin." 1999. The Journal of Biological Chemistry. 274(26):18536-8542. DOI:10.1074/jbc.274.26.18536]
  12. [[12] Granger DN, Senchenkova E. Inflammation and the Microcirculation. San Rafael (CA): Morgan & Claypool Life Sciences; 2010. Chapter 7, Leukocyte–Endothelial Cell Adhesion]
  13. 13.0 13.1 13.2 [[13] "Gas Gangrene." 2011. The New York Times: Health Guide.]